March 5, 2020 / 12:22 PM / 24 days ago

BRIEF-Rocket Pharmaceuticals Reports Qtrly Loss Per Share Of $0.39

March 5 (Reuters) - Rocket Pharmaceuticals Inc:

* ROCKET PHARMACEUTICALS REPORTS FULL YEAR 2019 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* ROCKET PHARMACEUTICALS QTRLY LOSS PER SHARE OF $0.39

* ROCKET PHARMACEUTICALS - AS OF DEC 31, 2019, CO HAD CASH, CASH EQUIVALENTS AND INVESTMENTS OF $304.1 MILLION

* ROCKET PHARMACEUTICALS - STRONG BALANCE SHEET WITH CASH RUNWAY INTO 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below